{"id":"NCT00688870","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan","officialTitle":"A PHASE 3, RANDOMIZED, ACTIVE-CONTROLLED, DOUBLE-BLIND TRIAL EVALUATING THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS GIVEN WITH ROUTINE PEDIATRIC VACCINATION IN TAIWAN","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06-05","primaryCompletion":"2010-01-13","completion":"2010-01-13","firstPosted":"2008-06-03","resultsPosted":"2011-05-12","lastUpdate":"2022-10-07"},"enrollment":168,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Vaccines","Pneumococcal Conjugate Vaccine"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent pneumococcal conjugate vaccine (13vPnC)","otherNames":[]},{"type":"BIOLOGICAL","name":"7-valent pneumococcal conjugate vaccine (7vPnC)","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC), relative to a 7-valent pneumococcal conjugate vaccine (7vPnC) when given concomitantly with routine vaccines in Taiwan.","primaryOutcome":{"measure":"Percentage of Participants Achieving a Predefined Antibody Level of Greater Than or Equal to 0.35 Micrograms (mcg)/mL, 1 Month After the Infant Series.","timeFrame":"1 month after the infant series (7 months of age)","effectByArm":[{"arm":"13vPnC","deltaMin":98.8,"sd":null},{"arm":"7vPnC","deltaMin":100,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"42 Days","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":2,"countries":["Taiwan"]},"refs":{"pmids":["22198517"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":83},"commonTop":["Irritability","Decreased appetite","Fever ≥ 38 degrees C but ≤ 39 degrees C","Increased sleep","Upper respiratory tract infection"]}}